Cargando…

Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody

The embryonic transcription factor brachyury is overexpressed in a variety of human tumors, including lung, breast, colon and prostate carcinomas, chordomas and hemangioblastomas. In human carcinoma cells, overexpression of brachyury associates with the occurrence of the phenomenon of epithelial-mes...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamilton, Duane H., Fernando, Romaine I., Schlom, Jeffrey, Palena, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467120/
https://www.ncbi.nlm.nih.gov/pubmed/25605015
_version_ 1782376328496939008
author Hamilton, Duane H.
Fernando, Romaine I.
Schlom, Jeffrey
Palena, Claudia
author_facet Hamilton, Duane H.
Fernando, Romaine I.
Schlom, Jeffrey
Palena, Claudia
author_sort Hamilton, Duane H.
collection PubMed
description The embryonic transcription factor brachyury is overexpressed in a variety of human tumors, including lung, breast, colon and prostate carcinomas, chordomas and hemangioblastomas. In human carcinoma cells, overexpression of brachyury associates with the occurrence of the phenomenon of epithelial-mesenchymal transition (EMT), acquisition of metastatic propensity and resistance to a variety of anti-cancer therapeutics. Brachyury is preferentially expressed in human tumors vs. normal adult tissues, and high levels of this molecule associate with poor prognosis in patients with lung, colon and prostate carcinomas, and in breast cancer patients treated with adjuvant tamoxifen. Brachyury is immunogenic in humans and vaccines against this novel oncotarget are currently undergoing clinical investigation. While our group and others have employed various anti-brachyury antibodies to interrogate the above findings, we report here on the development and thorough characterization of a novel rabbit monoclonal antibody (MAb 54-1) that reacts with distinct high affinity and specificity with human brachyury. MAb 54-1 was successfully used in ELISA, western blot, immunofluorescence and immunohistochemistry assays to evaluate expression of brachyury in various human tumor cell lines and tissues. We propose the use of this antibody to assist in research studies of EMT and in prognostic studies for a range of human tumors.
format Online
Article
Text
id pubmed-4467120
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-44671202015-06-22 Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody Hamilton, Duane H. Fernando, Romaine I. Schlom, Jeffrey Palena, Claudia Oncotarget Research Paper The embryonic transcription factor brachyury is overexpressed in a variety of human tumors, including lung, breast, colon and prostate carcinomas, chordomas and hemangioblastomas. In human carcinoma cells, overexpression of brachyury associates with the occurrence of the phenomenon of epithelial-mesenchymal transition (EMT), acquisition of metastatic propensity and resistance to a variety of anti-cancer therapeutics. Brachyury is preferentially expressed in human tumors vs. normal adult tissues, and high levels of this molecule associate with poor prognosis in patients with lung, colon and prostate carcinomas, and in breast cancer patients treated with adjuvant tamoxifen. Brachyury is immunogenic in humans and vaccines against this novel oncotarget are currently undergoing clinical investigation. While our group and others have employed various anti-brachyury antibodies to interrogate the above findings, we report here on the development and thorough characterization of a novel rabbit monoclonal antibody (MAb 54-1) that reacts with distinct high affinity and specificity with human brachyury. MAb 54-1 was successfully used in ELISA, western blot, immunofluorescence and immunohistochemistry assays to evaluate expression of brachyury in various human tumor cell lines and tissues. We propose the use of this antibody to assist in research studies of EMT and in prognostic studies for a range of human tumors. Impact Journals LLC 2014-12-26 /pmc/articles/PMC4467120/ /pubmed/25605015 Text en Copyright: © 2015 Hamilton et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Hamilton, Duane H.
Fernando, Romaine I.
Schlom, Jeffrey
Palena, Claudia
Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody
title Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody
title_full Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody
title_fullStr Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody
title_full_unstemmed Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody
title_short Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody
title_sort aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467120/
https://www.ncbi.nlm.nih.gov/pubmed/25605015
work_keys_str_mv AT hamiltonduaneh aberrantexpressionoftheembryonictranscriptionfactorbrachyuryinhumantumorsdetectedwithanovelrabbitmonoclonalantibody
AT fernandoromainei aberrantexpressionoftheembryonictranscriptionfactorbrachyuryinhumantumorsdetectedwithanovelrabbitmonoclonalantibody
AT schlomjeffrey aberrantexpressionoftheembryonictranscriptionfactorbrachyuryinhumantumorsdetectedwithanovelrabbitmonoclonalantibody
AT palenaclaudia aberrantexpressionoftheembryonictranscriptionfactorbrachyuryinhumantumorsdetectedwithanovelrabbitmonoclonalantibody